Aptevo Therapeutics Inc banner

Aptevo Therapeutics Inc
NASDAQ:APVO

Watchlist Manager
Aptevo Therapeutics Inc Logo
Aptevo Therapeutics Inc
NASDAQ:APVO
Watchlist
Price: 4.44 USD 1.6% Market Closed
Market Cap: $4.4m

Income Statement

Earnings Waterfall
Aptevo Therapeutics Inc

Income Statement
Aptevo Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Revenue
Revenue
34
N/A
30
-11%
19
-36%
15
-19%
10
-36%
4
-59%
11
+177%
15
+30%
15
+0%
17
+13%
20
+20%
20
-2%
23
+18%
19
-18%
12
-36%
6
-48%
0
N/A
0
N/A
0
N/A
2
+309%
4
+123%
7
+56%
9
+39%
11
+17%
12
+12%
13
+6%
10
-24%
7
-31%
3
-54%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Gross Profit
Cost of Revenue
(17)
(17)
(12)
(13)
(12)
(7)
(10)
(8)
(5)
(9)
(8)
(9)
(11)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Gross Profit
17
N/A
13
-20%
7
-46%
3
-60%
(2)
N/A
(3)
-27%
1
N/A
6
+670%
10
+50%
8
-16%
12
+46%
11
-8%
12
+9%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(78)
(76)
(70)
(72)
(65)
(135)
(135)
(60)
(64)
(63)
(65)
(66)
(64)
(68)
(59)
(53)
(41)
(37)
(36)
(31)
(32)
(33)
(35)
(35)
(34)
(33)
(32)
(32)
(32)
6
(31)
(30)
(29)
(28)
(26)
(25)
(25)
(24)
(24)
(27)
(26)
Selling, General & Administrative
(43)
(43)
(39)
(42)
(36)
(37)
(38)
(34)
(35)
(32)
(31)
(30)
(28)
(25)
(22)
(19)
(16)
(15)
(14)
(13)
(14)
(14)
(16)
(16)
(15)
(15)
(14)
(14)
(14)
(14)
(13)
(12)
(12)
(11)
(11)
(11)
(10)
(10)
(10)
(12)
(12)
Research & Development
(35)
(34)
(31)
(30)
(29)
(27)
(26)
(26)
(29)
(31)
(34)
(36)
(35)
(34)
(30)
(29)
(25)
(22)
(20)
(17)
(18)
(19)
(19)
(19)
(19)
(18)
(18)
(18)
(18)
(17)
(19)
(18)
(17)
(17)
(15)
(14)
0
(14)
(14)
(15)
(15)
Other Operating Expenses
0
0
0
0
0
(71)
(71)
0
0
0
0
0
0
(9)
(7)
(4)
0
0
(2)
0
0
0
0
0
0
0
0
0
0
37
0
0
0
0
0
0
(15)
0
0
0
0
Operating Income
(61)
N/A
(63)
-3%
(63)
0%
(69)
-10%
(68)
+2%
(138)
-104%
(134)
+3%
(54)
+60%
(54)
+0%
(55)
-3%
(53)
+4%
(55)
-3%
(52)
+6%
(49)
+5%
(47)
+4%
(47)
+1%
(41)
+12%
(37)
+9%
(36)
+4%
(29)
+20%
(27)
+4%
(27)
+3%
(26)
+4%
(24)
+6%
(21)
+11%
(20)
+6%
(22)
-9%
(25)
-14%
(29)
-15%
6
N/A
(31)
N/A
(30)
+4%
(29)
+4%
(28)
+3%
(26)
+8%
(25)
+5%
(25)
-2%
(24)
+4%
(24)
-1%
(27)
-10%
(26)
+1%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Non-Reccuring Items
0
0
0
(71)
(71)
0
0
0
0
0
0
0
0
0
0
0
0
(2)
0
(2)
(2)
0
0
0
0
0
37
37
37
0
0
0
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
10
10
0
0
0
0
0
0
0
0
Total Other Income
(0)
0
0
(0)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(4)
(6)
(8)
(9)
(9)
(7)
(2)
1
3
3
1
1
1
1
0
0
0
0
0
Pre-Tax Income
(61)
N/A
(63)
-2%
(63)
0%
(141)
-124%
(140)
+1%
(139)
+0%
(136)
+2%
(56)
+59%
(56)
0%
(57)
-2%
(55)
+4%
(57)
-3%
(54)
+6%
(51)
+4%
(49)
+4%
(49)
+1%
(43)
+12%
(41)
+4%
(37)
+10%
(32)
+14%
(31)
+4%
(29)
+8%
(30)
-4%
(30)
0%
(29)
+2%
(30)
-1%
6
N/A
6
-12%
7
+26%
17
+138%
(19)
N/A
(18)
+8%
(19)
-6%
(27)
-46%
(25)
+8%
(24)
+5%
(24)
+0%
(24)
+1%
(24)
-1%
(26)
-10%
(26)
+2%
Net Income
Tax Provision
2
2
2
19
20
21
21
17
23
0
0
8
0
0
0
1
0
0
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(59)
(61)
(61)
(122)
(120)
(119)
(115)
(39)
(33)
(35)
(34)
(49)
(54)
(51)
(49)
(48)
(43)
(41)
(37)
(33)
(31)
(29)
(30)
(30)
(29)
(30)
6
6
7
17
(19)
(18)
(19)
(27)
(25)
(24)
(24)
(24)
(24)
(26)
(26)
Net Income (Common)
(59)
N/A
(61)
-3%
(56)
+8%
(115)
-105%
(112)
+3%
(109)
+3%
(108)
+2%
2
N/A
7
+290%
3
-56%
1
-64%
(49)
N/A
(54)
-9%
(52)
+3%
(52)
0%
(46)
+11%
(40)
+13%
(26)
+37%
(19)
+26%
(19)
+1%
(18)
+6%
(28)
-57%
(29)
-4%
(29)
-1%
(28)
+3%
(29)
-2%
7
N/A
6
-9%
8
+25%
18
+130%
(17)
N/A
(16)
+8%
(17)
-8%
(27)
-55%
(25)
+8%
(24)
+5%
(24)
-1%
(24)
+1%
(24)
-1%
(28)
-16%
(28)
+1%
EPS (Diluted)
-1 797.48
N/A
-1 854.06
-3%
-1 706.24
+8%
-3 495.96
-105%
-3 406.51
+3%
-3 219.7
+5%
-3 080.59
+4%
51.05
N/A
199.22
+290%
85.11
-57%
29.15
-66%
-1 333
N/A
-1 451.05
-9%
-1 440.36
+1%
-5 203 999.99
-361 199%
-4 640 200
+11%
-612.84
+100%
-2 553 300
-416 534%
-1 900 400
+26%
-1 887 100
+1%
-1 774 999.99
+6%
-2 790 300
-57%
-2 903 199.99
-4%
-2 923 800
-1%
-2 845 700
+3%
-2 889 800
-2%
704 400
N/A
639 700
-9%
802 699.99
+25%
1 849 699.99
+130%
-1 746 099.99
N/A
-807 549.99
+54%
-870 550
-8%
-540 379.99
+38%
-95 965.38
+82%
-30 022.78
+69%
-1 200 000
-3 897%
-5 852.09
+100%
-585.83
+90%
-124.25
+79%
-29.1
+77%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett